Transgene Biotek Limited (BOM:526139)
2.460
-0.170 (-6.46%)
At close: Jan 20, 2026
Transgene Biotek Revenue
Transgene Biotek had revenue of 528.00K INR in the quarter ending September 30, 2025, a decrease of -9.74%. This brings the company's revenue in the last twelve months to 2.55M, up 29.12% year-over-year. In the fiscal year ending March 31, 2025, Transgene Biotek had annual revenue of 2.61M with 10.98% growth.
Revenue (ttm)
2.55M
Revenue Growth
+29.12%
P/S Ratio
72.71
Revenue / Employee
n/a
Employees
n/a
Market Cap
185.64M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 2.61M | 258.00K | 10.98% |
| Mar 31, 2024 | 2.35M | 1.80M | 326.32% |
| Mar 31, 2023 | 551.00K | -315.95K | -36.44% |
| Mar 31, 2022 | 866.95K | -828.55K | -48.87% |
| Mar 31, 2021 | 1.70M | 1.66M | 4,642.12% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Regent Enterprises | 10.04B |
| Onesource Industries and Ventures | 1.03B |
| Benchmark Computer Solutions | 530.89M |
| Indong Tea Company | 307.59M |
| Raunaq lnternational | 285.18M |
| Neo Infracon | 112.82M |
| Veer Energy & Infrastructure | 80.34M |
| Steel Strips Infrastructures | 39.72M |